Effectiveness of Pulpotomy vs. Root Canal Treatment in Extremely Deep Caries

November 17, 2025 updated by: National University Hospital, Singapore

Effectiveness of Pulpotomy vs. Root Canal Treatment in Extremely Deep Caries: A Randomized Controlled Trial Conducted in Supervised Undergraduate Clinics

Recent clinical trials comparing pulpotomy versus root canal treatment (RCT) have shown promising outcomes; however, the current evidence lacks generalisability to general practitioners. It remains to be elucidated whether these favourable results can be replicated in a primary care setting. This study aims to address that gap by involving senior dental students undergoing supervised university education and training, with the potential to inform future best practice guidelines and promote the adoption of vital pulp therapy (VPT) as a predictable treatment alternative in the general dental population.

The clinical procedure involves complete caries-free excavation carried out under rubber dam isolation. After confirming vital pulp status-demonstrated by bleeding upon entry, participants will be randomised to receive one of two treatments: RCT or full pulpotomy.

Outcomes will include clinical and radiographic success or failure of the intervention at 12 months. Additionally, patient-reported outcomes will be collected, specifically pain experienced and the use of analgesia during the immediate post-operative period (days 3 and 7).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Singapore, Singapore
        • Recruiting
        • National University Centre For Oral Health Singapore (NUCOHS)
        • Contact:
        • Principal Investigator:
          • Victoria Yu, PhD
        • Sub-Investigator:
          • Angela Lin, BDS
        • Sub-Investigator:
          • Ming Yi Tan, MDS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 12 years or older
  • Mature maxillary or mandibular permanent tooth with extremely deep restorations/caries penetrating the entire thickness of dentine on the radiograph without a radiopaque zone separating the lesion from the pulp (Bjorndal et al., 2019)
  • Tooth may or may not be symptomatic at the time of recruitment but must be responsive to cold and EPT sensibility testing
  • Tooth is restorable and can be adequately isolated during treatment
  • One tooth per patient

Exclusion Criteria:

  • Teeth with difficult access and unpredictable isolation using a rubber dam
  • Teeth aberrant root canal morphology, extreme root curvatures (>30 degrees), calcified canals/sclerosed pulp
  • Teeth indicated for elective root canal treatment for restorative purposes
  • Teeth with apical periodontitis
  • Presence of apical radiolucency
  • Any evidence of purulence or excessive bleeding that cannot be controlled with a cotton pellet with 1.25% hypochlorite for 10 minutes
  • History of trauma to the tooth
  • Teeth with active periodontal disease (pocket depth >5mm)
  • Patients with complex medical histories that may affect their caries experience and healing ability (immunocompromised, radiotherapy etc.)
  • Patients who are pregnant or breast-feeding
  • Patients who are unable to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Full Pulpotomy

The intra-operative standard care for pulpotomy is as follows:

  • Clinical procedure should be completed over one or 2 visits
  • Performed under local anaesthesia and rubber dam isolation
  • Complete caries removal
  • Pulp resection using sterile high-speed bur with water coolant
  • Irrigation protocol with 1.25% sodium hypochlorite
  • Haemostasis with a 1.25% sodium hypochlorite-moistened cotton pellet over the amputated pulps for up to 10 minutes
  • Placement of Biodentine (Septodont Ltd., Saint Maur des Fausse s, France) or its alternative approved by NUCOHS for pulpotomy
  • Final definitive resin-based restoration
  • Post-operative periapical radiograph taken
Preservation of vital pulp tissue for tooth survival.
Active Comparator: Root Canal Treatment

The intra-operative standard care for root canal treatment is as follows:

  • Clinical procedure can be carried out over one or 2 visits
  • Use of rubber dam mandatory
  • Irrigation protocol with 1.25% sodium hypochlorite
  • Working length with combined radiographs and apex locators
  • Automated instrumentation to accompany hand instrumentation
  • Preparation to apical size 2-3 larger than largest file that binds at the WL in the uninstrumented canal initial apical file (IAF)
  • Canal medicament; non setting calcium hydroxide if done in two visits
  • Root canal filling with gutta pecha and traditional sealers (cold lateral or warm vertical condensation)
  • Ensure coronal seal
  • Good quality postoperative radiograph using parallel cone technique
  • Final restoration as per undergraduate clinical protocols
Root canal treatment as a comparator to pulpotomy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary Outcome
Time Frame: 12 months
Clinical and radiographic success or failure of the intervention will be measured at 12 months. The primary outcome is a composite measure at 12 months: 1) absence of pain indicative of unhealthy pulp; 2) absence of signs and symptoms indicative of acute or chronic periapical disease; 3) absence of radiographic evidence of failure including radiolucency or resorption. Failure of any part of the composite, at or any time before 12 months, will equate to overall treatment failure.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary Outcome
Time Frame: 12 months
A patient reported outcome of pain experienced and use of analgesia in the immediate post-operative period (days 3, 7) will be collected through a paper questionnaire distributed at visit 1. The presence of a structurally integral tooth with an intact, nondefective restoration at 12 months, with positive sensibility response to EPT and with absence of need for any further intervention during the 12-month follow-up period, presence of calcification or adverse event will be reported on. A parallel health economics analysis will be completed using data collected from participants at baseline and at 12 months using common agreed templates.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 16, 2025

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

November 17, 2025

First Posted (Actual)

November 21, 2025

Study Record Updates

Last Update Posted (Actual)

November 21, 2025

Last Update Submitted That Met QC Criteria

November 17, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-4505

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Only anonymised data can be shared, subject to local health records governance.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulpitis

Clinical Trials on Full Pulpotomy

Subscribe